Related Experiment Video

Updated: Aug 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

The role of statins in chronic kidney disease

Rajiv Agarwal1, Timothy M Curley

  • 1Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, 46202, USA. ragarwal@iupui.edu

The American Journal of the Medical Sciences
|August 17, 2005
PubMed

Insights

Patients with chronic kidney disease (CKD) have high cardiovascular event rates, making CKD a cardiovascular disease risk equivalent. Treating dyslipidemia in CKD patients is crucial for reducing cardiovascular events and slowing kidney function decline.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Syndrome

Background:

  • Chronic kidney disease (CKD) is a significant cardiovascular disease risk equivalent, exhibiting high rates of cardiovascular events.
  • Dyslipidemia is prevalent in CKD patients, mirroring patterns seen in metabolic syndrome, and is a known risk factor for kidney function impairment.
  • Dyslipidemia is linked to progressive renal disease in individuals with and without overt kidney disease, including diabetic and non-diabetic kidney disease.

Purpose of the Study:

  • To evaluate the role of dyslipidemia treatment in managing cardiovascular events and renal function decline in patients with chronic kidney disease.
  • To assess the impact of statin therapy on proteinuria and kidney function in the context of CKD and dyslipidemia.

Main Methods:

  • Review of collective evidence on dyslipidemia and its impact on cardiovascular and renal outcomes in CKD.
  • Analysis of the effects of statin therapy, including high-dose use, on proteinuria and renal function.
  • Consideration of ongoing definitive randomized controlled trials examining statin safety and efficacy in cardiovascular and renal protection.

Main Results:

  • Treatment of dyslipidemia in CKD patients is associated with a reduction in cardiovascular events.
  • Evidence suggests that treating dyslipidemia is linked to a slower decline in renal function.
  • High-dose statins may cause transient proteinuria but lead to long-term reduction in proteinuria and slower kidney function decline.

Conclusions:

  • Chronic kidney disease patients should be screened and treated for dyslipidemia due to its significant cardiovascular and renal implications.
  • Statins show promise in reducing proteinuria and slowing renal function decline in CKD patients, although further definitive trials are ongoing.
  • Dyslipidemia management is a critical component of comprehensive care for patients with chronic kidney disease to mitigate cardiovascular and renal risks.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...